ScripHaving successfully landed their anti-PD-1 Loqtorzi (toripalimab) in the US, Shanghai Junshi Biosciences Co., Ltd. and Coherus BioSciences, Inc. are set to jump-start a partnership bonanza for pot
In VivoAs 2022 draws to a close, an unusually low number of marquee deals have been made in the biopharma sector. But it has been a hectic year nonetheless, with a high volume of deal-making and the lower va
ScripOn Oct. 24, the China biotech sector has suffered its largest single-day drop across the board as investors dumped US-listed shares in the wake of the changes to China's top political leadership. Even
ScripWho: Jemincare and Genentech What: The two companies have signed a licensing agreement around Jemincare’s androgen receptor degrader, JMKX002992. Why: The drug’s target is a confirmed disease dri